Efficient Targeting of FATS at a Common Fragile Site in Mice Through TALEN-mediated Double-hit Genome Modification
Overview
Biotechnology
Authors
Affiliations
Transcription activator-like effector nucleases (TALENs) have emerged as a newly developed approach for genome editing. However, its application in targeting specific genomic loci susceptible to DNA damage remains obscure. Here, we report a modified approach for TALENs-based targeting of FATS, a fragile-site gene whose major introns have AT-rich sequence and di-nucleotide repeats. Two pairs of FATS-TALENs were designed to cleave two sites specifically at a coding exon of FATS. After in vitro transcription, the mRNA from FATS-TALEN pairs was microinjected into mouse zygotes. The targeting efficiency of two FATS-TALEN pairs in vivo was more than threefold higher than that of one FATS-TALEN pair. Moreover, large-size DNA deletions were detected, which were heritable and easily detectable by PCR. Our study indicates that the double-hit TALEN approach enhances targeting efficiency in vivo and provides convenience for monitoring germline transmission of mutations by PCR, which will facilitate the functional research on fragile-site genes.
Phan H, Kim K, Lee H, Seong J Genes (Basel). 2023; 14(2).
PMID: 36833410 PMC: 9957140. DOI: 10.3390/genes14020483.
Human pluripotent stem cell models of Fragile X syndrome.
Bhattacharyya A, Zhao X Mol Cell Neurosci. 2015; 73:43-51.
PMID: 26640241 PMC: 4867245. DOI: 10.1016/j.mcn.2015.11.011.
Damaging the Integrated HIV Proviral DNA with TALENs.
Strong C, Guerra H, Mathew K, Roy N, Simpson L, Schiller M PLoS One. 2015; 10(5):e0125652.
PMID: 25946221 PMC: 4422436. DOI: 10.1371/journal.pone.0125652.
Application of oocyte cryopreservation technology in TALEN-mediated mouse genome editing.
Nakagawa Y, Sakuma T, Nakagata N, Yamasaki S, Takeda N, Ohmuraya M Exp Anim. 2014; 63(3):349-55.
PMID: 25077765 PMC: 4206739. DOI: 10.1538/expanim.63.349.
Yasue A, Mitsui S, Watanabe T, Sakuma T, Oyadomari S, Yamamoto T Sci Rep. 2014; 4:5705.
PMID: 25027812 PMC: 4099983. DOI: 10.1038/srep05705.